BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4121944)

  • 1. Hyperviscosity syndrome in multiple myeloma.
    Lancet; 1973 Feb; 1(7799):359-60. PubMed ID: 4121944
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperviscosity in IgG myeloma: detection and treatment in community medical facilities.
    Seward CW; Osterland CK
    Tex Med; 1974 Mar; 70(3):63-5. PubMed ID: 4818033
    [No Abstract]   [Full Text] [Related]  

  • 3. [Myeloma serum hyperviscosity syndrome treated with plasmapheresis].
    Radović M; Durić D; Trajković B; Radojicić B; Pekic B; Tomasević R; Dujić A
    Med Pregl; 1977; 30(9-10):471-6. PubMed ID: 600211
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum viscosity and hyperviscosity syndrome in IgG multiple myeloma. Report on 10 patients and a review of the literature.
    Pruzanski W; Watt JG
    Ann Intern Med; 1972 Dec; 77(6):853-60. PubMed ID: 4644164
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of blood hyperviscosity syndrome with continuous plasma exchange using a Fenval CS 3000 separator in patients with multiple myeloma].
    Usnarska-Zubkiewicz L; Gola A
    Pol Tyg Lek; 1993 Feb 1-8; 48(5-6):123-5. PubMed ID: 8361907
    [No Abstract]   [Full Text] [Related]  

  • 6. [Plasmapheresis and hyperviscosity syndrome].
    Corral Alonso M; Barbolla ML
    Sangre (Barc); 1984; 29(5):940-50. PubMed ID: 6441295
    [No Abstract]   [Full Text] [Related]  

  • 7. The hyperviscosity syndrome. I. In IgG myeloma. The role of protein concentration and molecular shape.
    MacKenzie MR; Fudenberg HH; O'Reilly RA
    J Clin Invest; 1970 Jan; 49(1):15-20. PubMed ID: 5409803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nursing assessment of symptoms associated with hyperviscosity syndrome.
    Trotta P; Knobf MT
    Oncol Nurs Forum; 1987; 14(1):21-5. PubMed ID: 3101042
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasmapheresis for hyperviscosity syndrome in macroglobulinemia Waldenström and multiple myeloma: influence on blood rheology and the microcirculation.
    Reinhart WH; Lutolf O; Nydegger UR; Mahler F; Straub PW
    J Lab Clin Med; 1992 Jan; 119(1):69-76. PubMed ID: 1727909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient removal of abnormal immunoglobulin G from plasma of a multiple myeloma patient. Description of a new method for treatment of the hyperviscosity syndrome.
    Ray PK; Besa E; Idiculla A; Rhoads JE; Bassett JG; Cooper DR
    Cancer; 1980 May; 45(10):2633-8. PubMed ID: 6155195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aggregation phenomenon in an IgG multiple myeloma resulting in the hyperviscosity syndrome.
    Benninger GW; Kreps SI
    Am J Med; 1971 Aug; 51(2):287-93. PubMed ID: 5095532
    [No Abstract]   [Full Text] [Related]  

  • 12. Hyperviscosity syndrome in association with kappa light chain myeloma.
    Carter PW; Cohen HJ; Crawford J
    Am J Med; 1989 May; 86(5):591-5. PubMed ID: 2496600
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyperviscosity syndrome with IgA myeloma.
    Dine ME; Guay AT; Snyder LM
    Am J Med Sci; 1972 Aug; 264(2):111-5. PubMed ID: 4653114
    [No Abstract]   [Full Text] [Related]  

  • 14. Hyperviscosity syndrome in plasma cell dyscrasias.
    Mehta J; Singhal S
    Semin Thromb Hemost; 2003 Oct; 29(5):467-71. PubMed ID: 14631546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hyperviscosity syndrome].
    Hashimoto T
    Nihon Rinsho; 1995 Mar; 53(3):695-8. PubMed ID: 7699907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of IgG lambda myeloma associated with hyperviscosity syndrome. A speculative mechanism of hyperviscosity syndrome with relative low serum viscosity (author's transl)].
    Katsuki A; Shimazaki C; Osamura K; Nakanishi S; Kayawake S; Sasaki T; Murano K; Nakata T; Nishio A; Hosoda M; Haruyama H; Matsushima K; Ijichi H; Isemura T
    Rinsho Ketsueki; 1979 Jun; 20(6):658-66. PubMed ID: 112269
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical study on therapeutic plasmapheresis--mechanism of its efficacy, indications, and clinical application. d. Hyperviscosity syndrome].
    Ito K
    Nihon Rinsho; 1984 Aug; 42(8):1870-4. PubMed ID: 6513056
    [No Abstract]   [Full Text] [Related]  

  • 18. [Whole blood, plasma and erythrocyte internal viscosities in hypergammaglobulinemia: their causal relations with hyperviscosity syndrome].
    Fujioka S
    Nihon Ketsueki Gakkai Zasshi; 1987 Aug; 50(5):1024-30. PubMed ID: 3434141
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experience with plasma exchange: application of an apparatus for plasmapheresis (Haemonetics Model 30) in hyperviscosity syndrome].
    Amamiya Y; Baba M; Hisamitsu J; Ito T; Amaki T
    Rinsho Ketsueki; 1978 Oct; 19(10):1436-8. PubMed ID: 105174
    [No Abstract]   [Full Text] [Related]  

  • 20. [Reestablishment of plasma proteins after plasmapheresis in patients with paraproteinemic hemoblastosis].
    Movshev BE; Kalinin NN; Petrov MM; Petrova VI
    Ter Arkh; 1999; 71(10):40-3. PubMed ID: 10612173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.